UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017140
Receipt number R000018968
Scientific Title A multicenter exploratory study on the usefulness of covered metalic stent with fins(New GENOS) for biliary obstruction caused by unresectable middle-lower bile duct malignant tumors
Date of disclosure of the study information 2015/04/14
Last modified on 2015/04/14 22:09:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter exploratory study on the usefulness of covered metalic stent with fins(New GENOS) for biliary obstruction caused by unresectable middle-lower bile duct malignant tumors

Acronym

A multicenter exploratory study on the usefulness of New GENOS

Scientific Title

A multicenter exploratory study on the usefulness of covered metalic stent with fins(New GENOS) for biliary obstruction caused by unresectable middle-lower bile duct malignant tumors

Scientific Title:Acronym

A multicenter exploratory study on the usefulness of New GENOS

Region

Japan


Condition

Condition

Middle-lower bile duct obstruction caused by malignant tumors such as pancreas cancer, Ampullary carcinoma, bile duct cancer, gallbladder cancer, malignant lymphoma, lymph node metastasis, etc

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the patency and safety of Covered Metallic Stent(CMS) with fins(New GENOS)

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

rate of stent migration

Key secondary outcomes

rate of recurrent biliary obstruction(RBO), time to recurrent biliary obstruction(TRBO)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

placement New GENOS stent to non-resectable distal malignant biliary obstruction

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

non-resectable distal malignant
biliary obstruction
Written informed consent was obtained
from all patients before the procedures

Key exclusion criteria

difficult to approach by endoscope
Patients with ascites
Patients with hilar obstruction
World Health Organization performance status of 4

Target sample size

35


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Isayama

Organization

Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Division name

Department of Gastroenterology

Zip code


Address

7-3-1 Hongo Bunkyo-ku, Tokyo, Japan 113-8655

TEL

81-3-3815-5411

Email

isayama-tky@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazunaga Ishigaki

Organization

Graduate School of Medicine, The University of Tokyo

Division name

Department of Gastroenterology

Zip code


Address

7-3-1 Hongo Bunkyo-ku, Tokyo, Japan 113-8655

TEL

81-3-3815-5411

Homepage URL


Email

ISHIGAKIKA-INT@h.u-tokyo.ac.jp


Sponsor or person

Institute

Graduate School of Medicine, The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

no

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2014 Year 09 Month 18 Day

Date of IRB


Anticipated trial start date

2014 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 04 Month 14 Day

Last modified on

2015 Year 04 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018968